Login
From:
Cassava Sciences, Inc.
(Uncensored)
subscribe
Cassava Sciences Completes Patient Enrollment for Pivotal Phase 3 Clinical Trial of Oral Simufilam in Alzheimer’s Disease | Cassava Sciences, Inc.
https://www.cassavasciences.com/news-releases/news-release-details/cassava-sciences-completes-patient-enrollment-pivotal-phase-3
links
backlinks
Roast topics
Find topics
Find it!
The Investor Relations website contains information about Cassava Sciences, Inc.'s business for stockholders, potential investors, and financial analysts.
